See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Research Area · Atherosclerosis

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
19500 11-dehydro Thromboxane B2 67910-12-7 ≥98% 66.848585635359 11-dehydro-thromboxane-b2 11-keto TXB2; 11-dehydro TXB2 metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis 66.848585635359
319500 11-dehydro Thromboxane B2-d4 - ≥99% deuterated forms (d1-d4) 41.575980662983 11-dehydro-thromboxane-b2-d4 11-keto TXB2-d4 GC/MS deuterium isotopes 11-dh-TXB2-d4 internal standards thromboxanes 11-dehydro-TXB2-d4 deuterated GC-MS LC/MS LC-MS mass spectrometry atherosclerosis 41.575980662983
519510 11-dehydro Thromboxane B2 EIA Kit - Monoclonal New - 2012-02-08 225.763667638633 11-dehydro-thromboxane-b2-eia-kit-monoclonal 11-dehydro TXB2 ELISA Kit 11-dehydro-TXB2 enzymes immunoassays EIAs ELISAs kits assays measures measurements competitive quantification thromboxanes A2 TXA2 arachidonic acids platelets aggregation vascular bronchial smooth muscles hydrolyzed plasma urine ex vivo activation intra-renal production metabolites kidneys metabolized dehydrogenases enzymes cytosolic aldehydes peroxisomes peroxisomal b-oxidations beta-oxidations .beta.-oxidations β-oxidations infusions study studies circulating half-life t1/2 2,3-dinor 11-dehydro-2,3-dinor gas chromatography mass spectrometry GC/MS dosing doses aspirin acetylsalicylic acid NSAIDS nonsteroidal anti-inflammatory drugs smokers levels non-enzymatically 519501 225.763667638633
10007239 11-dehydro Thromboxane B2 Lipid Maps MS Standard 67910-12-7 ≥98% 2009-01-16 20.087947908445 11-dehydro-thromboxane-b2-lipid-maps-ms-standard 11-dehydro TXB2; 11-keto TXB2 metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis MS mass spectrometry standards 20.087947908445
10006831 11-dehydro Thromboxane B2 Quant-PAK - 2005-08-08 25.818526703499 11-dehydro-thromboxane-b2-quant-pak Quant-PAKs metabolites thromboxanes plasma deuterium isotopes 11-dh-TXB2-d4 internal standards 11-dehydro-TXB2-d4 deuterated GC/MS GC-MS LC/MS LC-MS mass spectrometry atherosclerosis packs 25.818526703499
160304 12-Lipoxygenase (murine leukocyte) Polyclonal Antiserum - 39.159723756906 12-lipoxygenase-murine-leukocyte-polyclonal-antiserum 12-LO; 12-LOX 12-LOs leukocyte 12-lipoxygenases western blots blotting WB antisera antibodies antiserum atherosclerosis immunoblotting 39.159723756906
34590 12(S)-HHTrE 54397-84-1 ≥97% 60.873812154695 12-s-hhtre 12(S)-HHT platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis 12(s)-hhtre 12(s)-hhtre 60.873812154695
10007250 12(S)-HHTrE Lipid Maps MS Standard 54397-84-1 ≥97% 2009-02-26 30.234077348066 12-s-hhtre-lipid-maps-ms-standard 12-HHT platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis MS mass spectrometry standards 30.234077348066
10010425 13,14-dihydro-15-keto Prostaglandin D1 Exclusive - >98% ✓ 2008-05-09 0.087679558011 13-14-dihydro-15-keto-prostaglandin-d1 13,14-dihydro-15-keto PGD1 PGD1 prostaglandins metabolites DGLA dihomo-.gamma.-linolenic acid dihomo-gamma-linolenic dihomo-y-linolenic PGDs pathways 0.087679558011
38601 (±)13-HODE cholesteryl ester 167354-91-8 ≥98% 8.645451197053 -13-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids (+/-)13-HODEs esters racemic 8.645451197053
10704 (±)13-HpODE 23017-93-8 ≥98% 2011-02-24 50.689198895028 -13-hpode hydroperoxides lipids linoleic acids reactive oxygen species oxidative stress injury 50.689198895028
38606 13(R)-HODE cholesteryl ester - ≥98% 1.347458563536 13-r-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13R-HODEs esters 1.347458563536
38611 13(S)-HODE cholesteryl ester - ≥98% 13.752762430939 13-s-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13S-HODEs esters 13(S)HODEs 13(S)-HODEs 13.752762430939
39620 13(S)-HOTrE 87984-82-5 ≥98% 2.540883977901 13-s-hotre linolenic acids hydroxy metabolites 13S-HOTrEs 13-HOTrEs fatty 13(S)-HOTrEs 13(S)HOTrEs 2.540883977901
48610 13(S)-HpODE 33964-75-9 >98% 112.839134438306 13-s-hpode linoleic hydroperoxides 13S-HpODEs 13-HpODEs hydroperoxy fatty acids 13(S)-HpODEs 112.839134438306
18570 15-deoxy-Δ12,14-Prostaglandin J2 87893-55-8 ≥95% 87.065636974572 15-deoxy-12-14-prostaglandin-j2 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2 atherosclerosis 87.065636974572
318570 15-deoxy-Δ12,14-Prostaglandin J2-d4 - ≥99% deuterated forms (d1-d4) 30.284861878453 15-deoxy-12-14-prostaglandin-j2-d4 15-deoxy-Δ12,14-PGJ2-d4 GC/MS deuterium isotopes 15-deoxy-DELTA12,14-PGJ2-d4 15-deoxy-.DELTA.12,14-PGJ2-d4 15-deoxy-D12,14-PGJ2-d4 internal standards prostaglandins deuterated mass spectrometry GC-MS LC-MS LC/MS atherosclerosis 30.284861878453
10007235 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard 87893-55-8 ≥97% 2009-01-16 38.002247928177 15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards 38.002247928177
160704 15-Lipoxygenase-1 (rabbit) Polyclonal Antiserum - 22.196445672191 15-lipoxygenase-1-rabbit-polyclonal-antiserum 15-LO-1; 15-LOX-1 15-LOs antibody Western blots 15-lipoxygenases blotting antisera antiserum antibodies atherosclerosis WB immunoblotting 22.196445672191
10010468 15-Lipoxygenase Inhibitor 1 Exclusive 928853-86-5 ≥98% ✓ 2008-10-23 34.525699815837 15-lipoxygenase-inhibitor-1 15-LO Inhibitor 1 15-LOs inhibitors inhibits inhibition oxidation inflammation thrombosis cancers lipoxygenases pyrimidobenzothiazine antioxidants 34.525699815837
13076 16(R)-Iloprost - ≥98% 2008-10-10 26.308745067087 16-r-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers inhibits inhibitors inhibition iloprosts PGI2 26.308745067087
13077 16(S)-Iloprost 74843-14-4 ≥98% 2008-10-10 27.445856353591 16-s-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers iloprosts inhibits inhibitors inhibition PGI2 27.445856353591
10010164 1-Octadecyl Lysophosphatidic Acid Exclusive 52977-29-4 ≥95% ✓ 2008-06-04 12.342384898710 1-octadecyl-lysophosphatidic-acid 1-Octadecyl LPA LPAs lysophosphatidic cells proliferation smooth muscles platelet aggregation neurite proteins sn-1 aggregating 12.342384898710
10010291 1-Octadecyl Lysophosphatidic Acid (sodium salt) Exclusive - ≥95% ✓ 2008-03-17 24.328342541436 1-octadecyl-lysophosphatidic-acid-sodium-salt 1-Octadecyl LPA LPA G-proteins receptors cell proliferations smooth muscle contractions platelet aggregations cell motility EDG receptors 24.328342541436
10009431 1-Stearoyl-2-Arachidonoyl PC-d8 Exclusive - ≥99% deuterated forms (d1-d8) ✓ 2009-07-24 8.713674033149 1-stearoyl-2-arachidonoyl-pc-d8 SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8 SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards 8.713674033149
515121 2,3-dinor-6-keto Prostaglandin F1α EIA Kit - 2006-05-23 148.800022099447 2-3-dinor-6-keto-prostaglandin-f1-eia-kit 2,3-dinor-6-keto PGF1α ELISA Kit solid plates enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays 148.800022099447
519051 2,3-dinor Thromboxane B2 EIA Kit - 120.509576484096 2-3-dinor-thromboxane-b2-eia-kit 2,3-dinor Thromboxane B2 ELISA Kit solid plates 2,3-dinor-TXB2 metabolites thromboxanes measures kits eias enzyme atherosclerosis immunoassays ELISAs assays 120.509576484096
10397 3-amino Benzamide 3544-24-9 ≥98% 2011-10-07 2.107037223058 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 2.107037223058
13221 3-hexanoyl-NBD Cholesterol - ≥98% 2009-06-05 2.693922651933 3-hexanoyl-nbd-cholesterol 3-C6-NBD Cholesterol fluorescent cholesterol NBD fluorophore membrane lipids flourescently-tagged probes 2.693922651933
9000368 3-hydroxy-3-methylglutaryl-Coenzyme A-d3 (ammonium salt) Exclusive - ≥99% deuterated forms (d1-d3) ✓ 2009-04-20 12.643646408840 3-hydroxy-3-methylglutaryl-coenzyme-a-d3-ammonium-salt HMG-CoA-d3 HMG-CoA mevalonic acid mevalonate cholesterol steroids sterols deuterateds deuterium standards GC MS LC mass spetrometry 12.643646408840
90500 3-Thiatetradecanoic Acid 116296-31-2 ≥98% 2004-02-06 1.169668508287 3-thiatetradecanoic-acid 3-TDA thioether myristic analogs PPAR ligands peroxisome proliferator-activated receptors oleic acids D9-desaturases .DELTA.9-desaturases DELTA9-desaturases atherosclerosis 1.169668508287
90312 4,5-dehydro Docosahexaenoic Acid - ≥98% 25.332228360957 4-5-dehydro-docosahexaenoic-acid 4,5-dehydro Cervonic Acid; 4,5-dehydro DHA w-3 fatty acids omega-3 .omega.-3 n-3 analogs acetylene 5-LO 5-lipoxygenases inhibits inhibitors 25.332228360957
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 136.023106200123 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 136.023106200123
60402 5-Lipoxygenase (human recombinant) - cell ly100,000 x g supernatant 38.545455801104 5-lipoxygenase-human-recombinant 5-LO; 5-LOX 5-LOs enzymes 5-lipoxygenases atherosclerosis active 38.545455801104
10009638 5-Lipoxygenase (human recombinant) Western Ready Control - 78 kDa (His-tagged), 74 kDa (native) 2007-07-27 9.837928176795 5-lipoxygenase-human-recombinant-western-ready-control 5-LOX; 5-LO western blot WB 5(S)-HETE arachidonic acids leukotrienes rat basophilic leukemia alveolar eosinophils mast epithelial lungs blood 9.837928176795
10007820 5-Lipoxygenase (Phospho-Ser523) Polyclonal Antibody - 2006-09-13 10.769070818684 5-lipoxygenase-phospho-ser523-polyclonal-antibody 5-LO (Phospho-Ser523) Polyclonal Antibody wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting 10.769070818684
160402 5-Lipoxygenase Polyclonal Antibody - 23.601900552485 5-lipoxygenase-polyclonal-antibody 5-LO; 5-LOX 5-LOs LTA4 asthma 5-lipoxygenases leukotrienes antisera western blots blotting WB antibodies antiserum icc immunocytochemistry atherosclerosis immunoblotting ihc immunohistochemistry 23.601900552485
10007601 5α-hydroxy-6-keto Cholesterol 13027-33-3 ≥98% 2005-11-11 112.798999014081 5-hydroxy-6-keto-cholesterol 6-Oxo-3,5-diol; Cholestane-6-oxo-3β,5α-diol atherosclerosis cholesterols ozonolysis cytotoxicity metabolites ozone-oxidized lipids surfactants lungs epithelials lining fluids exposures cells bronchalveoalar lavaged homogenates inhibits inhibitors synthesis bronchial cytotoxicity toxic oxysterols hydroxycholesterol 112.798999014081
15210 6-keto Prostaglandin F1α 58962-34-8 >99% 60.953138121546 6-keto-prostaglandin-f1 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis 60.953138121546
315210 6-keto Prostaglandin F1α-d4 - ≥99% deuterated forms (d1-d4) 19.680176795580 6-keto-prostaglandin-f1-d4 6-keto PGF1α-d4 GC/MS deuterium isotopes 6-keto-PGF1a-d4 6-keto-PGF1alpha-d4 6-keto-PGF1.alpha.-d4 internal standards prostaglandins PGFα deuterated LC/MS GC-MS LC-MS mass spectrometry d4 atherosclerosis 19.680176795580
515211 6-keto Prostaglandin F1α EIA Kit - 332.470368409385 6-keto-prostaglandin-f1-eia-kit 6-keto Prostaglandin F1α ELISA Kit solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays 332.470368409385
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 39.352254143646 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 39.352254143646
10312 8,12-iso-iPF2α-VI-1,5-lactone Exclusive - ≥98% ✓ 2009-08-07 3.642375690607 8-12-iso-ipf2-vi-1-5-lactone lactone IPF2α -I iPF2α-VI F2-iP urine lipid peroxidation plasma biomarker oxidative stress 214894-81-2 214894-83-4 3.642375690607
10007850 9,11-methane-epoxy Prostaglandin F1α 72517-81-8 >96% 2006-05-10 145.879318600368 9-11-methane-epoxy-prostaglandin-f1 9,11-Epoxymethano PGH1 prostaglandins PGs endoperoxides TXs thromboxanes prostacyclins PGH1 platelets smooth muscles analogs aggregation aorta aortic tracheas histamines coronary perfusion atherosclerosis 145.879318600368
38401 (±)9-HODE cholesteryl ester 33783-76-5 ≥98% 17.991565377532 -9-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters (+/-)9-HODEs (+/-)-HODEs (+/-)HODEs racemic 17.991565377532
38406 9(R)-HODE cholesteryl ester - ≥98% 1.721767955801 9-r-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters 9R-HODEs 9-HODEs 9(R)-HODEs 9(R)HODEs 1.721767955801
38410 9(S)-HODE 73543-67-6 ≥98% 22.434648776637 9-s-hode linoleic acids hydroxy oxidized 9S-HODEs 9-HODEs fatty 9(S)-HODEs 9(S)HODEs 22.434648776637
38411 9(S)-HODE cholesteryl ester - ≥98% 3.730138121547 9-s-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids hydroxy fatty acids 9-HODEs esters 9S-HODEs 9(S)-HODEs 9(S)HODEs 3.730138121547
338410 9(S)-HODE-d4 - ≥99% deuterated forms (d1- d4) 20.920441988950 9-s-hode-d4 GC/MS deuterium isotopes 9-HODE-d4 standards 9S-HODE-d4 deuterated GC-MS LC/MS LC-MS 9-HODEs 9(S)-HODEs 9S-HODEs 9(S)HODES hydroxy fatty acids 9(S)HODE-d4 mass spectrometry 20.920441988950
100028 ACAT-1 Polyclonal Antibody - 2004-04-28 25.977710933769 acat-1-polyclonal-antibody Sterol O-Acyltransferase 1; Acyl-coenzyme A: Cholesterol Acyltransferase-1; Cholesterol Acyltransferase 1; SOAT1 Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis antibodies antisera antiserum western blots blotting wb icc immunocytochemistry ihc immunohistochemistry immunoblotting 25.977710933769
100027 ACAT-2 Polyclonal Antibody - 2004-04-26 22.451535365937 acat-2-polyclonal-antibody Sterol O-Acyltransferase 2; Acyl-coenzyme A: Cholesterol Acyltransferase-2 Acyl-coenzyme A: cholesterol acyltransferase-2 esters ACAT2 atherosclerosis antibodies antisera antiserum western blots blotting wb icc immunocytochemistry ihc immunohistochemistry immunoblotting 22.451535365937
10007686 Acetyl Podocarpic Acid Anhydride Exclusive 344327-48-6 ≥98% ✓ 2007-07-11 110.879739103745 acetyl-podocarpic-acid-anhydride APD receptors ABC1 ABCA1 oxysterol cholesterol LXRalpha LXR.alpha. LXRbeta LXR.beta. 7.alpha.-hydroxylase RXR retinoid agonists nuclear receptors atherosclerosis acetyls podocaysics acids anhydrides livers hormones atherosclerosis 110.879739103745
589451 AcSDKP EIA Kit - 102.523756906077 acsdkp-eia-kit N-Acetyl Ser-Asp-Lys-Pro EIA Kit; AcSDKP ELISA Kit N-Acetyl-Seryl-Aspartyl-Lysyl-Proline serine aspartamine lysine measures kits eias enzyme immunoassays ELISAs growth regulatory hormones plasma urine spi-bio spibio A05881 atherosclerosis hypertension endocrinology assays 102.523756906077
10092 Adenosine Receptor A2A Blocking Peptide - 2009-04-03 189.773494475138 adenosine-receptor-a2a-blocking-peptide A2AR blocking peptides Western blots immunoblotting ARA2A 189.773494475138
10006908 Adipogenesis Assay Kit - 2006-08-18 97.724003444898 adipogenesis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays cell based assay cba 97.724003444898
10009381 Adipolysis Assay Kit - 2007-07-30 52.117738993721 adipolysis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay cell based assay cba 52.117738993721
10008492 Adipose Triglyceride Lipase Blocking Peptide - 2006-06-27 1.265193370166 adipose-triglyceride-lipase-blocking-peptide ATGL; TG-hydrolase inducible PLA2-ζ; Desnutrin antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis 1.265193370166
10006409 Adipose Triglyceride Lipase Polyclonal Antibody - 2005-11-23 9.941270718232 adipose-triglyceride-lipase-polyclonal-antibody Phospholipase A2ζ; Desnutrin; ATGL antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis immunoblotting 9.941270718232
19023 AH 23848 (calcium salt, hydrate) - ≥90% 2009-02-26 76.191248618784 ah-23848-calcium-salt-hydrate AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 76.191248618784
10010241 AICAR 2627-69-2 ≥98% 2008-02-25 204.096817679557 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 204.096817679557
589301 Angiotensin II EIA Kit - 172.169052688316 angiotensin-ii-eia-kit Angiotensin II ELISA Kit hypertension angiotensin measures kits eias enzyme immunoassays ELISAs spi-bio spibio A05880 atherosclerosis endocrinology assays 172.169052688316
580170 ANGPTL3 (human) EIA Kit New - 2012-01-10 53.539463299131 angptl3-human-eia-kit Angiopoietin-like protein 3 kits assays measures measurements angiopoietin-like proteins ANGPTLs angiopoietin-related growth factors AGF ligands regulated regulation angiogenesis glucose lipids energy metabolisms ANGPTL1 ANGPTL2 ANGPTL4 ANGPTL5 ANGPTL6 ANGPTL7 N-terminal N-terminus coiled-coil domains C-terminal C-terminus fibrinogen-like angiopoietins receptors Tie2 proteins Tie1 livers pro-angiogenic integrins αvβ3 endothelial cells migration adhesion inhibits inhibitors inhibition catalytic lipoproteins lipases catalyzes hydrolysis triglycerides HDL high density phospholipids hypolipidemic obese ob KK/Snk mice mouse expression hyperlipidemia atherosclerosis plasma human cholesterols immunometrics sandwich serums cultures supernatants 53.539463299131
13079 ApoAI Blocking Peptide - 2008-09-30 14.779558011050 apoai-blocking-peptide Apolipoprotein A-I; Apolipoprotein AI antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots 14.779558011050
13042 ApoAI Monoclonal Antibody (Clone CC3821C4) Exclusive - ✓ 2008-10-15 21.742115232833 apoai-monoclonal-antibody-clone-cc3821c4 Apolipoprotein AI antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins 21.742115232833
10008463 ApoAI Polyclonal Antibody - 2006-03-30 31.128004143646 apoai-polyclonal-antibody Apolipoprotein A-I; Apolipoprotein AI atherosclerosis proteins diseases antibodies antisera antiserum WB western blotting ICC immunocytochemistry ApoA1 ApoA-1 Apo A-1 Apo A1 Apo AI Apo-A1 Apo-AI blots immunoblotting 31.128004143646
10009751 ApoAI Western Ready Control - 2007-07-11 16.261850828729 apoai-western-ready-control Apolipoprotein AI western blots WB high-density lipoproteins HDL liver phospholipids excretion steroidogenesis blotting ApoA-1 atherosclerosis ApoA1 ApoA-I 16.261850828729
70260 Aspirin 50-78-2 >99% 2.845864352549 aspirin Acetylsalicylic Acid atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits 2.845864352549
10010153 Aspirin™ Effect-Detection Kit - 2007-06-08 64.708784700907 aspirin-effect-detection-kit use:human 11-dehydro-TXB2 enzyme immunoassays ELISAs kits measures metabolites atherosclerosis thromboxanes eias analysistools:eia atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits atherosclerosis assays 64.708784700907
10005292 Atherosclerosis Product Pack - 2004-09-09 4.426165745856 atherosclerosis-product-pack Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis inhibitors inhibits inhibition CETP WB blots blotting IHC immunohistochemistry JTT-705 89450 packs 4.426165745856
589401 Atriopeptin (rat) EIA Kit - 21.162430939227 atriopeptin-rat-eia-kit Atriopeptin (rat) ELISA Kit naturiuretic auriculin measures kits eias enzyme immunoassays ELISAs atherosclerosis pi-bio spibio A05103 hypertension endocrinology assays 21.162430939227
60924 Azelaoyl PAF - >98% 43.427316495658 azelaoyl-paf PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors 43.427316495658
10010266 BAY-11-7082 19542-67-7 ≥98% 2008-07-25 33.128187845303 bay-11-7082 inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 33.128187845303
18230 Beraprost (sodium salt) 88475-69-8 >98% 76.308876611418 beraprost-sodium-salt TRK 100; Procyclin; ML 1129 prostaglandins inhibitors inhibits PGI2 prostacyclin platelets aggregation pulmonary atherosclerosis hypertension analogs salts ML-1129 ML1129 TRK-100 TRK100 Na+ 76.308876611418
10006427 Berberine 633-65-8 ≥95% 2005-05-25 10.617831491713 berberine Umbellatine; BBR natural alkoloid hypocholesterolemic activity berberidaceaen medicine antiprotozoal antidiahreal agents reduces total cholesterol LDLR low-density lipoproteins triglycerides high fat diet LDL-receptors proteins mRNA levels hepatocytes serum atherosclerosis 10.617831491713
10009145 Bezafibrate 41859-67-0 ≥98% 2007-08-02 4.950850828729 bezafibrate Difaterol; Bezatrol; Bezalip; BM 15075; Benzofibrate PPAR PPAR.alpha. PPAR.delta. PPAR.gamma. agonist Pan-PPAR cholesterol atherosclerosis metabolic syndromes LDL HDL proliferator-activated receptors diabetes low-density high-density lipoproteins atherosclerosis cardiovascular PPARa PPARd PPARg endocrinology fibrate 4.950850828729
10010517 BIBB 515 156635-05-1 ≥98% 2008-06-16 0.824088397790 bibb-515 inhibitor inhibits inhibition BIBB515 OSC LDL 2,3-oxidosqualene cyclase cholesterol BIBB-515 0.824088397790
120114 BLT1 Receptor Polyclonal Antibody - 6.180524861878 blt1-receptor-polyclonal-antibody Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc atherosclerosis immunoblotting FC 6.180524861878
100019 BLT1 Receptor Polyclonal Antiserum - 2.877071823204 blt1-receptor-polyclonal-antiserum Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 C-terminus C-terminal intracellular plasma membranes whole cells LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc chronic pancreatitis pancreatic cancers pancreas atherosclerosis immunoblotting FC 2.877071823204
120124 BLT2 Receptor Polyclonal Antibody - 122.215911602209 blt2-receptor-polyclonal-antibody Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2 LTB4R2 LTB4-R2 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera western blots blotting WB atherosclerosis immunoblotting 122.215911602209
10155 BM 567 284464-77-3 >98% 2005-03-31 43.370676795580 bm-567 platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege 43.370676795580
60928 Butanoyl PAF - >98% 5.806546961326 butanoyl-paf ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis 5.806546961326
60929 Butenoyl PAF - >98% 3.819160220994 butenoyl-paf ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis 3.819160220994
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 8.183425414364 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 8.183425414364
18210 Carbaprostacyclin 69552-46-1 >99% 82.885651144435 carbaprostacyclin Carbacyclin; cPGI analogs vasodilation PPARs peroxisome proliferator-activated receptors PGI2 prostaglandins atherosclerosis cPGI Carbacyclin 82.885651144435
9000183 Carbaprostacyclin methyl ester Exclusive 69552-55-2 ≥98% ✓ 2010-11-29 20.166906077348 carbaprostacyclin-methyl-ester prostacyclins prostaglandins I2 PGI2 IPs PPARδ stable analog activate activation 20.166906077348
19010 Carbocyclic Thromboxane A2 74034-56-3 >98% 7.788453038674 carbocyclic-thromboxane-a2 CTA2; Carbocyclic TXA2 thromboxanes analogs TXA2 vasoconstriction CTA2 atherosclerosis 7.788453038674
13187 Cardiogenol C (hydrochloride) 671225-39-1 ≥97% 2009-02-06 3.462044198895 cardiogenol-c-hydrochloride Embryonic stem cells Differentiation Cardiomyocytes Cardiac muscle GATA-4 MEF2 Nkx2.5 3.462044198895
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 95.979825046041 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 95.979825046041
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 64.277476979742 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 64.277476979742
10006482 CAY10485 615264-62-5 ≥98% 2005-05-03 14.975684468999 cay10485 3,4-dihydroxy Hydrocinnamic acid (L-Aspartic acid dibenzyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs low density lipoproteins cholesterols acyl-coenzyme A: cholesterol acyltransferase-1 catalyzes esters ACAT-1 ACAT-2 low density lipoproteins oxidations ACAT1 ACAT2 14.975684468999
10006452 CAY10486 615264-52-3 ≥98% 2005-05-09 17.103647285802 cay10486 4-Hydroxycinnamic acid (L-phenylalanine methyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs cholesterols acyl-coenzyme A:cholesterol acyltransferase-1 catalyzes esters ACAT-1 ACAT-2 low density lipoproteins oxidations ACAT1 ACAT2 17.103647285802
10006480 CAY10487 778624-05-8 >98% 2005-03-29 6.240046040515 cay10487 3,4-Dihydrocinnamic Acid (L-alanine methyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs cholesterols low-density lipoproteins foam cells fatty streaks arterial walls lesions thoracic aortas lipids ACAT-1 ACAT-2 ACAT1 ACAT2 6.240046040515
10007875 CAY10499 Exclusive 359714-55-9 ≥98% ✓ 2006-07-25 12.579852670350 cay10499 obesity lipases diabetes triglycerides diacylglycerol inhibitors steroidogenesis spermatogenesis atherosclerosis HSL hormone sensitive endocrinology 12.579852670350
10009536 CAY10512 Exclusive 139141-12-1 ≥97% ✓ 2007-07-18 28.156942909760 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 28.156942909760
10009017 CAY10514 868526-38-9 ≥98% 2007-01-24 5.527983425414 cay10514 Methyl-8-hydroxy-8-(2-pentyl-oxyphenyl)-oct-5-ynoate peroxisome proliferator-activated receptors aromatics analogs 8-HETEs 8S-HETE 8(S)-HETE agonists PPARa PPARalpha PPAR.alpha. PPARg PPARgamma PPAR.gamma.atherosclerosis 5.527983425414
16835 CAY10580 Exclusive 64054-40-6 ≥96% ✓ 2009-03-16 77.803241252302 cay10580 PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis 77.803241252302
10012424 CAY10583 Exclusive 862891-27-8 ≥98% ✓ 2009-07-21 61.190257826887 cay10583 LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation 61.190257826887
13181 CAY10590 Exclusive 1101136-50-8 ≥98% ✓ 2009-04-15 14.872604577742 cay10590 sPLA2 cPLA2 iPLA2 phospholipases inhibitors R-gamma-nonleucine inhibition inhibited secreetory regulates phagocytosis foam cells 14.872604577742
10012536 CAY10592 Exclusive 685139-10-0 ≥98% ✓ 2009-02-26 26.856961325966 cay10592 selective PPARδ agonist HDLs LDLs TGs lipids metanolism plasma rats L6 cells lines APOB100 CETP-Tgn mice mouse transactivation assays CETPTgn CETP Tgn 26.856961325966
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 55.690121546961 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 55.690121546961
13282 CAY10599 Exclusive 1143573-33-4 ≥98% ✓ 2009-07-21 39.161461019030 cay10599 thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs 39.161461019030
10804 CAY10649 Exclusive 1272519-89-7 ≥98% ✓ 2011-04-04 16.559235727440 cay10649 5-LO leukotrienes 5-lipoxygenases inhibitors inflammation smooth muscle contraction inhibition inhibited PMNL inflammatory 16.559235727440
188150 CD36 Monoclonal Antibody (Clone JC63.1) - 19.629787505311 cd36-monoclonal-antibody-clone-jc63-1 Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC 19.629787505311
10009893 CD36 Monoclonal Antibody (Clone JC63.1) (azide free) Exclusive - ✓ 2010-03-03 22.701510128913 cd36-monoclonal-antibody-clone-jc63-1-azide-free GPIV; oxLDL; Thrombospondin Receptor; Hexarelin Receptor; GPIIIb antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC leukemia lymphocytic 22.701510128913
10009870 CD36 Monoclonal FITC Antibody (Clone JC63.1) - 2008-03-17 63.614659300184 cd36-monoclonal-fitc-antibody-clone-jc63-1 Thrombospondin Receptor; Hexarelin Receptor; GPIIIb; OxLDL Receptor; GPIV type-B atherosclerotic lesions fatty acids PPAR.gamma. expression flow cytometry immunocytochemistry FC ICC IF immunofluorescence 63.614659300184
100011 CD36 Polyclonal Antibody - 38.341979742172 cd36-polyclonal-antibody Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb type scavengers receptors atherosclerotic lesions glycoprotiens membranes PPAR.gamma. PPARgamma antibodies atherosclerosis CD-36 western blots blotting peroxisome proliferator-activated GP-IIIb GP-IV GP-3b GP-4 WB atherosclerosis immunoblotting 38.341979742172
10010250 Cellular Retinol Binding Protein 7 Polyclonal Antibody - 2007-10-16 5.946309392265 cellular-retinol-binding-protein-7-polyclonal-antibody Retinoid Binding Protein 7; cRBP7; RET7; Cellular Retinol Acid-Binding Protein IV western blots WB ICC immunocytochemistry micronutrient cell growth differentiation CRBPs RBP4 RBP7 atherosclerosis blotting immunoblotting IHC immunohistochemistry 5.946309392265
10007171 Cetaben 55986-43-1 ≥98% 2005-11-11 1.577348066298 cetaben Hexadecylamino-p-amino Benzoic Acid clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology 1.577348066298
10012447 CG 4305 - ≥95% 2010-05-12 49.515730071033 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 49.515730071033
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 63.879109883364 chemokine-like-receptor-1-polyclonal-antibody GPCR ChemR23; Resolvin E1 Receptor; ChemerinR; DEZ; CMKLR1; ChemR23 immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR 63.879109883364
10011286 Chenodeoxycholic Acid 474-25-9 ≥95% 2009-02-25 30.085602209944 chenodeoxycholic-acid Ulmenide; Kebilis; Anthropodeoxycholic Acid; Hekbilin; Fluibil; CDCA FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA 30.085602209944
10007640 Cholesterol Assay Kit - 2006-02-28 132.952672126909 cholesterol-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis assays fluorescent fluorometric 1007640 132.952672126909
10009779 Cholesterol Cell-Based Detection Assay Kit - 2007-05-04 48.472629425004 cholesterol-cell-based-detection-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis fluorescent fluorometric assays cell-based assay cell based assays cba U18666A U 18666A U-18666A 48.472629425004
600440 Cholesterol Uptake Cell-Based Assay Kit - 2011-06-28 42.757211797601 cholesterol-uptake-cell-based-assay-kit assays kits measures measurements cells hormones intermediates bile acids biosynthesis body cholesterols homeostasis de novo dietary absorption biliary clearance excretion plasma hypercholesterolemia cardiovascular diseases serum hepatic Ezetimibe inhibitors inhibits inhibition intestinal uptake enterocytes proteins Niemann-Pick C1 Like 1 NPC1L1 genes influx efflux intraluminal molecules membranes modulators NBD cultured U18666A inhibitor inhibits inhibition positive controls U 18666A U-18666A 42.757211797601
48001 Cholesteryl Linoleate Hydroperoxides - ≥98% hydroperoxide content 22.565569060773 cholesteryl-linoleate-hydroperoxides autoxidation atherosclerosis LDL HDL hydroperoxy fatty acids 22.565569060773
10010060 ChREBP Cell-Based Translocation Assay Kit - 2007-08-15 15.116227308603 chrebp-cell-based-translocation-assay-kit Carbohydrate Response Element-Binding Protein Cell-Based Translocation Assay Kit assays kits transcription factors TFs diabetes nutrients hormones hormonal regulation genes encoding enzymes glucose metabolisms lipogenesis dephosphorylated cytoplasm protein Ser196 nucleus liver obesity tolerance drugs discovery modulators sub-cellular localization ICC immunocytochemical stains staining antibody antibodies DylightTM Thermo Scientific, Inc. DyLightTM Pierce Biotechnology Inc. fluorescence fluorescent fluorometric endocrinology cell-based assay cell based assay cba 15.116227308603
10006909 ChREBP Transcription Factor Assay Kit - 2006-07-12 35.729531422018 chrebp-transcription-factor-assay-kit Carbohydrate Response Element-Binding Protein tf chrebps carbohydrate response element binding protein glucose liver insulin obesity adipokines endocrinology assays 35.729531422018
71730 Ciglitazone 74772-77-3 ≥98% 45.614659811745 ciglitazone U-63287; ADD 3878 nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology 45.614659811745
18216 Ciprostene (calcium salt) 81703-55-1 ≥98% 38.628701657458 ciprostene-calcium-salt U-61431F; Ciprostene calcium PGI2 analogs vasodilation 9.beta.-methyl 9beta-methyl carbaprostacyclin prostaglandins salts cat U61431F atherosclerosis 38.628701657458
10004235 cis-Resveratrol 61434-67-1 >98% (may contain 1-5% trans) 2008-02-05 30.205534069981 cis-resveratrol (Z)-Resveratrol antioxidant oxidative stress reactive oxygen species reactive nitrogen species ROS RNS NF-kb inflammations monoamine oxidase noradrenaline inhibits inhibitor inhibitions NF.kappa. atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 30.205534069981
10956 Clofibrate 637-07-0 ≥98% 2004-09-14 10.768753836709 clofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate 10.768753836709
160110 COX-1 Monoclonal Antibody (Clone CX111) - 43.556733425414 cox-1-monoclonal-antibody-clone-cx111 PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1 prostaglandins inflammation cancer arthritis antibodies cox1 pghs1 pghs-1 synthases cyclooxygenases western blots blotting WB antisera antiserum immunohistochemistry IHC immunocytochemistry ICC antisera antiserum atherosclerosis immunoblotting 43.556733425414
160109 COX-1 (mouse) Polyclonal Antibody - 38.138908839779 cox-1-mouse-polyclonal-antibody PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1 prostaglandins inflammation cancer arthritis antibodies mouse cox1 pghs1 pghs-1 cyclooxygenase-1 cyclooxygenases synthase-1 synthases antiserum antisera western blots blotting wb IHC immunohistochemistry atherosclerosis immunoblotting 38.138908839779
10011236 C-Reactive Protein (human) EIA Kit - 2009-04-22 312.046850828728 c-reactive-protein-human-eia-kit CRP (human) EIA Kit atherosclerosis proteins hepatocytes adipocytes plasma blood inflammatory inflammation physiological pathological atherogenesis endothelial coagulation ICAM-1 VCAM-1 E-selectin LDL macrophages plaques immunometric assays enzyme immunoassay ELISAs 312.046850828728
120500 CysLT1 Receptor Polyclonal Antibody - 71.259303867403 cyslt1-receptor-polyclonal-antibody Cysteinyl Leukotriene Receptor 1 cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT1 human flow cytometry asthma peptido-leukotrienes FACS antisera immunochemistry icc immunohistory ihc antiserum wb western blotting blots atherosclerosis immunoblotting immunocytochemistry immunohistochemistry FC 71.259303867403
13202 Daidzin 552-66-9 ≥98% 2011-09-30 5.582375690608 daidzin NPI 031D; Daidzoside isoflavones soy kudzu anti-oxidants cancers oxidants stress atherosclerosis inhibitor inhibits inhibition mitochondrial aldehydes dehydrogenases 2 alcohols plants anticarcinogenic anti-carcinogenic anti carcinogenic antioxidants antidipsotropic dipsotropic anti-dipsotropic anti-atherosclerosis antiatherosclerosis atherosclerosis 1329-08-4 28572-56-7 NPI-031D NPI031D 7-glucoside glucosides 5.582375690608
10012577 Diallyl Trisulfide 2050-87-5 ≥98% 2009-04-07 13.105030536273 diallyl-trisulfide DATS; NSC 651936 garlic hydrogen sulfides H2S cancers tumors smooth muscle cholesterol atherosclerosis donors supresses colon synthesis genes expression adenocarcinomas HCT-15 cells PC-3 xenografts 13.105030536273
62237 Diphenyl-1-pyrenylphosphine 110231-30-6 ≥98% 2006-07-25 83.155549416820 diphenyl-1-pyrenylphosphine DPPP hydroperoxides oxidative stress injury fluorescence fluorescent lipids cholesterols LDL oxidation DPPPO DPPP=O atherosclerosis 83.155549416820
10005057 Docosahexaenoic Acid-d5 - ≥99% deuterated forms (d1-d5) 2005-03-16 218.188360957642 docosahexaenoic-acid-d5 Cervonic Acid-d5; DHA-d5 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension 218.188360957642
9090310 Docosahexaenoic Acid ethyl ester 1020718-25-5 ≥98% 2009-01-15 68.145290055248 docosahexaenoic-acid-ethyl-ester DHA ethyl ester; Cervonic Acid ethyl ester fish oils anti-inflammatory antiiflammatory cardiovascular polyunsaturated fatty acids PUFAs DHAs neural tissues retina brain learning diet nutrition oxidation vision liver function muscle tone competitive inhibitors inhibits inhibition metabolism 68.145290055248
101640 DP1 Receptor Polyclonal Antibody - 2004-10-22 22.917776243093 dp1-receptor-polyclonal-antibody Prostaglandin D2 Receptor 1; PGD2 Receptor 1 isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting 22.917776243093
10011296 (E)-Guggulsterone 39025-24-6 ≥98% 2009-12-03 2.875138121547 -e-guggulsterone anti-flammatory cancers FXR bile acids LDL cholesterol antiinflammatory atherosclerosis obesity diabetes inflammation farnesoid X receptors guggul trees 2.875138121547
10008884 Eicosapentaenoic Acid ethyl ester 86227-47-6 ≥98% 2009-01-29 70.995414364641 eicosapentaenoic-acid-ethyl-ester EPA-EE; EPA ethyl ester fish oils anti-inflammatory anitinflammatory cardiovascular polyunsaturated fatty acids PUFAs EPAs nutrition oxidation competitive inhibitors inhibits inhibition metabolism cholesterol triglycerides insulin resistance adiponectin high fat diet high-fat TNFα 70.995414364641
100030 Endothelial Lipase Polyclonal Antibody - 2004-01-05 4.447410681399 endothelial-lipase-polyclonal-antibody EDL; EL antibodies antisera antiserum western blots blotting wb icc immunocytochemistry atherosclerosis special:month specialdiscount:15 specialstart:2008-03-01 specialend:2008-03-31 immunoblotting IHC immunohistochemistry 4.447410681399
583151 Endothelin EIA Kit - 223.882651933701 endothelin-eia-kit ET EIA Kit; Endothelin ELISA Kit atherosclerosis ET-1 vascular vasoconstriction measures kits eias enzyme immunoassays ELISAs endocrinology assays 223.882651933701
60880 eNOS (bovine recombinant) - cell lysate 100,000 x g supernatant 5.920345303867 enos-bovine-recombinant ecNOS; NOS III; Endothelial Nitric Oxide Synthase endothelial enzymes nitric oxide synthases cow atherosclerosis active 5.920345303867
160880 eNOS Polyclonal Antiserum - 6.449337016574 enos-polyclonal-antiserum ecNOS; NOS III; Endothelial Nitric Oxide Synthase synthases Western blots cells EDRF vasculature antisera blotting WB antibodies antiserum atherosclerosis immunoblotting IP immunoprecipitation 6.449337016574
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 30.416372007366 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 30.416372007366
10010019 FABP2 Polyclonal Antibody - 2007-10-02 3.441397000789 fabp2-polyclonal-antibody I-FABP; Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2 WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting 3.441397000789
10233 FABP3 Monoclonal Antibody (Clone CC68) - 2009-03-20 5.425531000613 fabp3-monoclonal-antibody-clone-cc68 Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting 5.425531000613
10007614 FABP4 (human) EIA Kit - 2006-10-13 21.150617581095 fabp4-human-eia-kit Fatty Acid Binding Protein 4 (human) EIA Kit; Adipocyte FABP (human) EIA Kit; A-FABP (human) ELISA Kit; aP2 10009284 SPI-BIO spibio ELISA immunoassay enzyme A05181 FABP4 fatty acid binding protein adipocytes aP2 atherosclerosis endocrinology assays 21.150617581095
10009549 FABP4 (human recombinant) - ≥90% 2007-06-15 16.343603909902 fabp4-human-recombinant A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 16.343603909902
9001068 FABP4 (human recombinant) FITC conjugated - ≥95% 2011-08-23 6.631610102604 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 6.631610102604
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 3.441008287292 fabp4-human-recombinant-western-ready-control Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 3.441008287292
10010231 FABP4 Inhibitor/Ligand Screening Assay Kit - 2007-11-01 14.448967275818 fabp4-inhibitor-ligand-screening-assay-kit aP2; Adipocyte FABP; A-FABP; Fatty Acid Binding Protein 4 fabps kits atherosclerosis assays fatty acid binding protein adipocytes aP2 cytosolic lipophilic ligands uptake metabolisms cellular membranes intracellular trafficking cells growth differentiation PPARg PPARgamma PPAR.gamma. peroxisomes proliferator-activated receptors agonists insulin genes deletion mice mouse murine chronic metabolic diseases diabetes atherosclerosis fluorescence fluorescent fluorometric endocrinology 14.448967275818
10005191 FABP4 (mouse recombinant) - ≥95% 2005-07-27 6.236795580110 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 6.236795580110
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 2.515782688766 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 2.515782688766
10004944 FABP4 Polyclonal Antibody - 2004-11-05 12.961649565904 fabp4-polyclonal-antibody Fatty Acid Binding Protein 4; aP2; A-FABP; ALBP; Adipocyte-FABP atherosclerosis adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARgamma agonists insulin WB western blots blotting ICC immunocytochemistry hyperinsulinemia deficiency antibodies antiserum antisera endocrinology immunoblotting 12.961649565904
10010364 FABP5 (human recombinant) - ≥95% 2007-08-08 10.600895027624 fabp5-human-recombinant Keratinocyte FABP; Psoriasis-Associated FABP; Fatty Acid Binding Protein 5; Epidermal-FABP; E-FABP; DA11 FABP proteins lipophilic ligands uptake metabolism cellular membranes FABP-5 FABPs cytosolic fatty acids bladders carcinoma prostates atherosclerosis endocrinology 10.600895027624
10007433 FABP5 (mouse recombinant) - ≥95% 2005-07-29 3.242867905575 fabp5-mouse-recombinant Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry 3.242867905575
10010501 Farnesyl Thiosalicylic Acid 162520-00-5 ≥96% 2008-06-02 18.336316758748 farnesyl-thiosalicylic-acid Salirasib; FTS ras inhibitors inhibition inhibits cancer anti-cancer anticancer prenylation farnesylation signal transduction oncogene atherosclerosis farnesylthiosalicylic acid 18.336316758748
10005368 Fenofibrate 49562-28-9 ≥98% 2004-09-15 12.769097605892 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology 12.769097605892
70440 Filipin III 480-49-9 ≥85% 63.282044198895 filipin-iii Filipin-3 Filipin-III Cholesterol fluorescent fluorescence atherosclerosis filipin 111 63.282044198895
10010337 Fluvastatin (sodium salt) 93957-55-2 ≥98% 2008-02-27 12.486676751732 fluvastatin-sodium-salt atherosclerosis HMG-CoA reductases LDL LDL-c HDL HDL-c statin cholesterol heart disease CVD inhibitors inhibits inhibition 12.486676751732
10039 FR122047 (hydrate) - ≥98% 13.770676795580 fr122047-hydrate 130717-51-0 FR-122047 cyclooxygenases COX-1 inhibitors hydrates hydrochlorides COX1 PGHS1 PGHS-1 prostaglandin synthases inhibition inhibits selective selectivity platelet aggregation antiinflammatory atherosclerosis 13.770676795580
70540 Furegrelate (sodium salt) 85666-17-7 ≥99% 2.544290976059 furegrelate-sodium-salt U-63557A thromboxanes synthases inhibitors inhibits inhibition salts atherosclerosis 2.544290976059
10006798 GW 0742 317318-84-6 ≥98% 2007-07-25 29.794281767955 gw-0742 PPAR PPAR.beta. PPAR.delta. peroxisome proliferator activated receptor neurotoxicity agonists neuroprotection toxicity apoptosis lipids metabolism atherosclerosis endocrinology GW0742 GW-0742 29.794281767955
10009880 GW 590735 Exclusive 622402-22-6 ≥98% ✓ 2007-06-18 9.053149171270 gw-590735 PPAR PPAR.alpha. PPAR.BETA. PPAR.gamma. PPAR.delta. receptor transcription factors lipidtriglyceride TG lipoprotein VLDL ApoCIII ApoA1 HDL atherosclerosis endocrinology 9.053149171270
10008613 GW 7647 265129-71-3 ≥98% 2006-08-02 21.838997632202 gw-7647 PPAR.alpha. peroxisome proliferator-activated receptor triglycerides lipid homeostasis transcription factor fibrate atherosclerosis endocrinology GW7647 21.838997632202
10011211 GW 9578 Exclusive 247923-29-1 ≥98% ✓ 2008-05-23 26.156961325966 gw-9578 atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated 26.156961325966
70785 GW 9662 22978-25-2 ≥98% 71.039342541436 gw-9662 GW-9662 GW9662 ligands ppar.gamma. ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis 71.039342541436
9000497 GW 9662-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2009-09-30 33.777096378146 gw-9662-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs 33.777096378146
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 53.702559852670 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 53.702559852670
10006084 Hesperetin 520-33-2 ≥98% 2005-02-16 18.941703220046 hesperetin hesperitin hesperidin atherosclerosis citrus nutraceuticals flavonoids flavanoids hypocholesterolemic ACAT2 ACAT-2 mRNA transcription inhibits inhibition inhibitors ApoB proteins histamines azelastine atherosclerosis 18.941703220046
13354 Hexacosanoic Acid 506-46-7 ≥98% 2009-07-24 6.570643714616 hexacosanoic-acid Cerotic Acid; NSC 4205; Ceric Acid fatty acids very long chain very-long-chain peroxisomes peroxisomals disorders adrenoleukodystrophy atherosclerosis metabolic syndromes red blood cells plasma ceratinic acids cerinic cerylic n-hexacosanoic cerolic acid 6.570643714616
10006371 Hormone Sensitive Lipase Polyclonal Antibody - 2005-06-22 9.506293738489 hormone-sensitive-lipase-polyclonal-antibody HSL; LIPE proteins antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry catalyses hydrolysis of tri- di- monoacylglycerols cholesterol esters mobilizes fatty acids primary source energy mammals enzyme expressed adipose tissues stearidonic steroidgenesis spermatogenesis foam cell formation atherosclerosis diabetic pathology human cDNA isoforms testis mRNA mouse murine macrophages testicular ram seminal vesicles triacylglycerols diacylglycerols atherosclerosis 9.506293738489
10699 HTS 01037 682741-29-3 ≥98% 2011-03-14 10.578715469613 hts-01037 adipocytes fatty acids binding proteins FABP4 AFABP A-FABP aP2 macrophages lipocytes diabetes atherosclerosis HTS-01037 HTS01037 Isomerases Amino Acid Acid Isomerases Amino Racemases Amino Acid Amino Acid Isomerases Acid Racemases Amino Amino Acid Racemases 10.578715469613
18215 Iloprost 78919-13-8 ≥97% 174.348213627993 iloprost Ciloprost agonists IP receptors vasodilator hypostensive atherosclerosis antiduretic hypertension analogs PGI2 prostaglandins prostacyclin selective selectivity pharma:21 174.348213627993
10809 Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) - 2011-06-03 2.646408839779 interleukin-33-human-monoclonal-antibody-clone-il33305b IL-1F11; IL-33; NF-HEV antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 2.646408839779
10811 Interleukin-33 Monoclonal Antibody (Clone IL33026B) - 2011-06-02 1.323204419889 interleukin-33-monoclonal-antibody-clone-il33026b NF-HEV; IL-33; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 1.323204419889
10810 Interleukin-33 Monoclonal Antibody (Clone IL333068A) - 2011-06-02 1.323204419889 interleukin-33-monoclonal-antibody-clone-il333068a IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay 1F11 IL1F11 interleukin 33 NFHEV NF HEV 1.323204419889
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 25.489591774094 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 25.489591774094
160070 IP Receptor (mouse) Polyclonal Antibody - 2004-05-25 19.648040515653 ip-receptor-mouse-polyclonal-antibody PGI2 Receptor; Prostacyclin Receptor; Prostaglandin I2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors atherosclerosis neurochemistry immunoblotting 19.648040515653
19021 I-SAP 133538-58-6 ≥98% 7.417679558011 i-sap Iodophenyl sulfonyl amino pinane Thromboxane A2; Iodophenyl sulfonyl amino pinane TXA2 thromboxanes ISAP pinane analogs agtagonists TP receptors atherosclerosis 7.417679558011
10011054 KB2115 Exclusive 355129-15-6 ≥98% ✓ 2008-06-10 24.467403314917 kb2115 thyroid hormones dyslipidemia LDL cholesterol statins cardiovascular disease atherosclerosis obesity 24.467403314917
62935 KDdiA-PC Exclusive 439904-34-4 >98% ✓ 2005-09-09 7.211920951975 kddia-pc CD36 ligands oxidized oxLDL low density lipoproteins particles cytotoxics pro-atherogenic phosphatidylcholines species short-chain fatty acids sn-2 scavengers receptors structural determinants binding affinity atherosclerosis 7.211920951975
62945 KOdiA-PC Exclusive 439904-33-3 ≥98% ✓ 2004-01-28 25.904601420678 kodia-pc oxidative injury lipids oxLDL oxidized low-density lipoproteins phosphatidylcholines CD36 CD-36 scavengers receptors binding atherosclerosis 25.904601420678
10009324 LCAT Blocking Peptide - 2007-01-03 22.338335635359 lcat-blocking-peptide Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol-O-Acyltransferase antibodies western blotting blots signaling signalling WB controls peptides proteins cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary 22.338335635359
10009323 LCAT Polyclonal Antibody - 2007-01-03 20.361933701658 lcat-polyclonal-antibody Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol O-Acyltransferase proteins diseases antibodies antisera antiserum WB western blots blotting cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary atherosclerosis immunoblotting 20.361933701658
10007672 LDL Receptor Blocking Peptide - 2007-05-03 14.513259668508 ldl-receptor-blocking-peptide Low-density Lipoprotein Receptor Blocking peptide; LDLR Blocking Peptide proteins diseases WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic livers hormonal controls mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 14.513259668508
10007665 LDL Receptor Polyclonal Antibody - 2006-02-15 43.384203699255 ldl-receptor-polyclonal-antibody LDLR; Low Density Lipoprotein Receptor proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic tails livers hormonal controls in vivo vitro mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 cell-based assay cell based assay cba immunoblotting 43.384203699255
10011125 LDL Uptake Cell-Based Assay Kit - 2008-04-29 42.048542987965 ldl-uptake-cell-based-assay-kit Low-Density Lipoprotein Uptake atherosclerosis cholestrols plasmas blood coronary heart diseases low-density lipoproteins kits assays assaying tools uptakes regulation 42.048542987965
10007817 Leukotriene A4 Hydrolase (human recombinant) - ≥90% 2005-12-14 275.808100344092 leukotriene-a4-hydrolase-human-recombinant LTA4H leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis active 275.808100344092
20110 Leukotriene B4 71160-24-2 ≥97% 180.943799155021 leukotriene-b4 LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis 180.943799155021
320110 Leukotriene B4-d4 - ≥99% deuterated forms (d1-d4) 143.486187845304 leukotriene-b4-d4 LTB4-d4 GC/MS LTB4-d4 deuterium internal standards isotopes leukotrienes GC-MS mass spectrometry LC/MS LC-MS deuterated spectroscopy atherosclerosis mass spectrometry 143.486187845304
520111 Leukotriene B4 EIA Kit - 1106.047323511356 leukotriene-b4-eia-kit Leukotriene B4 ELISA Kit solid plates neutrophils 5-LOs 5-lipoxygenases LTB4 measures kits atherosclerosis eias enzyme immunoassays ELISAs leukotrienes assays 1106.047323511356
10007240 Leukotriene B4 Lipid Maps MS Standard 71160-24-2 ≥97% 2009-01-14 29.751524861878 leukotriene-b4-lipid-maps-ms-standard LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards 29.751524861878
520411 Leukotriene E4 EIA Kit - 178.613555643251 leukotriene-e4-eia-kit Leukotriene E4 ELISA Kit solid plates kitrecommendation:cyslt allergy cys-LTs cysteinyl-leukotrienes atherosclerosis neutrophils LTE4 measures kits eias enzyme immunoassays ELISAs asthma cysteinyl-LTs peptido-LTs peptido-leukotrienes assays 178.613555643251
89430 Linolein Hydroperoxides - >98% (A mixture of 132 isomers) 22.052734806630 linolein-hydroperoxides trilinoleins autoxidation atherosclerosis isomers hydroperoxy fatty acids 22.052734806630
705002 Lipid Hydroperoxide (LPO) Assay Kit - 270.184910497238 lipid-hydroperoxide-lpo-assay-kit lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress atherosclerosis assays 270.184910497238
705003 Lipid Hydroperoxide (LPO) Assay Kit (96 well) - 174.978715469613 lipid-hydroperoxide-lpo-assay-kit-96-well lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress assays 174.978715469613
10010338 Lovastatin 75330-75-5 ≥98% 2008-03-03 10.317160598762 lovastatin LDL-c cholesterol HMG-CoA reductase HMGCoA statins heart diseases CVD atherosclerosis HDL-c NF-kB NF-.kappa.B TNF-.alpha. apoptosis anti-cancer mevacor Altocor mevinolin inhibits inhibitors inhibition 10.317160598762
10010339 Lovastatin Hydroxy Acid (sodium salt) Exclusive - >98% ✓ 2008-03-04 12.599079189686 lovastatin-hydroxy-acid-sodium-salt atherosclerosis LDL cholesterol HMG-CoA reductase statin heart disease CVD LDL-c HDL HDL-c inhibitors inhibits inhibition 12.599079189686
10010971 Luminex® 11-dehydro Thromboxane B2 Kit - 2008-01-24 43.918881343360 luminex-11-dehydro-thromboxane-b2-kit Luminex® 11-dehydro TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 43.918881343360
10010228 Lyso-PAF C-18 -d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-11-03 18.899071823204 lyso-paf-c-18-d4 PAFs platelet-activating factors deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 18.899071823204
10010497 Manumycin A 52665-74-4 ≥98% 2008-06-25 16.571464088398 manumycin-a UCF 1C; NSC 622141 farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB 16.571464088398
90290 MEDICA 16 87272-20-6 >98% 12.588950276242 medica-16 hypolipidemic antidiabetogenic analogs fatty acids diabetes antidiabetic b,b'-hexadecanedioic nuclear receptors beta,beta-hexadecanedioic .beta.,.beta.'-hexadecanedioic VLDL decrease atherosclerosis 12.588950276242
600160 Methionine Sulfoxide Immunoblotting Kit - 2009-12-17 234.812994475138 methionine-sulfoxide-immunoblotting-kit MetO Immunoblotting Kit proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 234.812994475138
10010340 Mevastatin 73573-88-3 ≥98% 2008-07-16 10.329502762430 mevastatin Statin I; NSC 281245; L 637312; Compactin; ML 236B; CS 500 atherosclerosis cholesterol HMG-CoA reductases statins heart diseases CVD LDL-c LDLc HDL-c HDLc TNF-.alpha. TNF-a TNF-alpha NF-kb NF-.kappa.B NF-kappaB apoptosis cancers cardiovascular TNF.alpha. inhibtis inhibitor inhibition HMGCoA pythium ultimum 10.329502762430
10006438 Myeloperoxidase Chlorination Assay Kit - 2009-04-14 121.104516574585 myeloperoxidase-chlorination-assay-kit MPO Chlorination Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes APF 2-[6-(4-aminophenoxy)-3-oxo3H-xanthen-9-yl]-benzoic acid hypochlorite -OCl 121.104516574585
10012600 Myricetin 529-44-2 >98% 2009-02-20 24.470613873541 myricetin NSC 407290; Cannabiscetin flavonoid antioxidant oxLDL CD36 atherosclerosis cancers JAK1 STAT3 MEK1 24.470613873541
63150 Myriocin 35891-70-4 >98% 2007-05-03 56.576548719507 myriocin Thermozymocidin; ISP-1 serine palmitoyltransferase inhibitors sphingolipids antibiotic immunosuppressants inhibition inhibited atherosclerosis 56.576548719507
13055 Naphthofluorescein 61419-02-1 ≥98% 2009-03-20 1.601988950276 naphthofluorescein CCG 8295 furin matrix metalloproteinase MTA-MMP MMP2 motility invasion cancer metastasis MMP inhibitors naphthafluorescein 1.601988950276
80230 NG,NG-dimethyl-L-Arginine (hydrochloride) 220805-22-1 >98% 21.695856353591 ng-ng-dimethyl-l-arginine-hydrochloride ADMA endogenous nitric oxide synthase inhibitors NOS renal failure preeclampsia inhibits inhibition asymmetric dimethylarginine hypercholesterolemia atherosclerosis muscular dystrophy 21.695856353591
189542 Nitrotyrosine Monoclonal Antibody - 29.279150552486 nitrotyrosine-monoclonal-antibody peroxynitrite nitric oxide superoxide oxidative injury stress Alzheimer's diseases antibodies NO western blots blotting WB nitration proteins antisera antiserum IHC immunohistochemistry immunoprecipitation IP atherosclerosis immunoblotting EIA enzyme immunoassays 29.279150552486
10009661 N-Octadecyl-N'-propyl-sulfamide - ≥95% 2008-04-23 6.284806629834 n-octadecyl-n-propyl-sulfamide PPAR.alpha. PPARa PPARalpha OEA satiety obesity metabolism food intake triglyceride lipids activators appetite suppression 6.284806629834
10010411 NS-304 475086-01-2 ≥98% 2008-04-09 39.075902394106 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 39.075902394106
10006782 Oleic Acid-2,6-diisopropylanilide 140112-65-8 ≥98% 2005-05-18 15.043721096787 oleic-acid-2-6-diisopropylanilide HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits low-density liproteins high-density inhibition atherosclerosis 15.043721096787
10006529 Oleyl Anilide 5429-85-6 ≥95% 2005-05-18 15.569043380397 oleyl-anilide OA; Oleic Acid Anilide HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits glycerides dioleoyl phenylamino propane 1,2-diols eosinophilia excessive T cell activation acute pulmonary inflammatory reactions TOS toxic oil syndrome aniline-denatured cooking oils interleukins atherosclerosis 15.569043380397
11614 Olmesartan Medoxomil New 144689-63-4 ≥98% 2012-05-18 99.077747084100 olmesartan-medoxomil Olmetec; Benicar; CS 866 prodrugs angiotensin II receptors antagonists blood pressure hypertension cardiovascular disease atherosclerosis CS866 CS 866 in vivo RNH-6270 RNH 6270 RNH6270 AT1 AT2 blood pressure cardiovascular parameters CS-866 99.077747084100
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 10.428937998772 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 10.428937998772
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 9.883163122942 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 9.883163122942
34004 Oxidized Lipid HPLC Mixture - >98% for each compound 19.050877839165 oxidized-lipid-hplc-mixture ROS peroxidation LDL atherosclerosis autoxidation reactive oxygen species (+/-)9-HODEs (+/-)13-HODEs esters (+/-)15-HETEs (+/-)-HODEs (+/-)-HETEs hydroxy fatty acids racemic (+/-)HODEs (+/-)HETEs cholesteryl esters 19.050877839165
9000395 Oxy-16 Exclusive 596-94-1 >95% ✓ 2010-09-15 28.282032688766 oxy-16 20(R),22(R)-dihydroxy Cholesterol oxysterols sterols hedgehogs bone formations cardiovascular diseases inflammation macrophage antagonist oxy16 16 26649-05-8 26622-99-1 4005-81-6 15234-55-6 Hhs signalling signaling oxy 16 Besins-Iscovesco Brand of Androstanolone Besins Iscovesco Brand of Androstanolone Berenguer Infale Brand of Androstanolone beta-Hydroxy-5 beta-Androstan-3-One, 17 17 beta-Hydroxy-5 beta-Androstan-3-One 17 beta Hydroxy 5 beta Androstan 3 One 17beta-Hydroxy-5alpha-Androstan-3-One 17beta Hydroxy 5alpha Androstan 3 One Cuxson Brand of Androstanolone 5-alpha Dihydrotestosterone 5 alpha-Dihydrotestosterone 5 alpha Dihydrotestosterone 5 beta-Dihydrotestosterone 5 beta Dihydrotestosterone Dihydroepitestosterone Steroids, Catatoxic Dihydrotestosterone Catatoxic Steroids Diflucortolone Androstanolone Pregnatrienes Norpregnenes Azasteroids 5-alpha-DHT 5 alpha DHT Ro 10-7614 Ro 10 7614 Stanolone Ro 107614 Andractim Anaprotin Steroids Cholenes Gelovit 28.282032688766
70515 Ozagrel 82571-53-7 ≥98% 3.360220994475 ozagrel OKY-046 thromboxanes synthases inhibitors inhibits imidizoles TXAs antihypertensive inhibition atherosclerosis 3.360220994475
10011301 p38 MAPK Monoclonal Antibody (Clone 9F12) - 2008-05-22 3.323351749539 p38-mapk-monoclonal-antibody-clone-9f12 p38 Mitogen-activated Protein Kinase; p38 MAPKα serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC 3.323351749539
10010374 p38 MAPK (Phospho-Thr180/Tyr182) Cell-Based Phosphorylation/Translocation Assay Kit - 2007-09-17 4.361010260458 p38-mapk-phospho-thr180-tyr182-cell-based-phosphorylation-translocation-assay-kit phosphorylation kits assays enzymes diseases asthma autoimmunity stress response nervous system fluorescence fluorescent fluorometric 4.361010260458
760901 PAF Acetylhydrolase Assay Kit - 110.877645027623 paf-acetylhydrolase-assay-kit PAF-AH; Lp-PLA2 PAF-AH colorimetric phospholipids atherosclerosis cytosolic extracellular platelet-activating factors PAFs enzymes analysistools:cytpafah analysistools:expafah assays paf elisa kit 110.877645027623
160603 PAF Acetylhydrolase (human) Polyclonal Antibody - 10.591215469613 paf-acetylhydrolase-human-polyclonal-antibody Platelet-activating Factor Receptor Acetylhydrolase; PAF-AH; Lp-PLA2 atherosclerosis platelet-activating factors Western blots asthma inflammation preeclampsia antisera PAFs WB antibodies antiserum blotting immunoblotting 10.591215469613
10010081 PAF Acetylhydrolase (human) Western Ready Control - 2007-05-30 2.592640883977 paf-acetylhydrolase-human-western-ready-control PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase; Lipoprotein PLA2 western blotting WB atherosclerosis factors asthma inflammation PAFs 2.592640883977
10004380 PAF Acetylhydrolase Inhibitor Screening Assay Kit - 2004-03-29 47.752897483117 paf-acetylhydrolase-inhibitor-screening-assay-kit PAF-AH Inhibitor Screening Assay Kit; Lp-PLA2 Inhibitor Screening Assay Kit platelet-activating factors hypotension inflammations allergys PAFAH atherosclerosis heart diseases measures kits inhibitors PAFs assays paf elisa kit 47.752897483117
60900 PAF C-16 74389-68-7 >98% 13.996712707182 paf-c-16 Platelet-activating Factor C-16 PAFs platelet-activating factors atherosclerosis 13.996712707182
360900 PAF C-16-d4 - ≥99% deuterated forms (d1-d4) 16.246022099448 paf-c-16-d4 Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis 16.246022099448
60910 PAF C-18 74389-69-8 >97% 17.985480662983 paf-c-18 PAFs platelet-activating factors atherosclerosis 17.985480662983
10010229 PAF C-18-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-11-03 18.859116022099 paf-c-18-d4 PAFs platelet-activating factors atherosclerosis deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 18.859116022099
160600 PAF Receptor (human) Monoclonal Antibody (11A4, Clone 21) - 21.703878453038 paf-receptor-human-monoclonal-antibody-11a4-clone-21 Platelet-activating Factor Receptor platelet-activating factors antibodies PAFs ICC immunocytochemistry antisera antiserum flow cytometry FACS receptors atherosclerosis PAFR FC 21.703878453038
160602 PAF Receptor (human) Polyclonal Antibody - 27.475944751381 paf-receptor-human-polyclonal-antibody Platelet-activating Factor Receptor platelet-activating factors antisera PAFs antiserum antibodies flow cytometry facs immunocytochemistry icc western blots blotting wb atherosclerosis PAFR FC immunoblotting 27.475944751381
10009871 Palmitoleic Acid 373-49-9 ≥99% 2008-08-25 12.430386740331 palmitoleic-acid Palmitoleate; cis-Palmitoleic Acid; 9-cis-Hexadecenoic Acid; n-7 Palmitoleate monounsaturated fatty acids LDL HDL cholesterol diet 12.430386740331
62924 PAz-PC 117746-89-1 >98% 2.884056827150 paz-pc Azelaoyl PC; 1-Palmitoyl-2-Azelaoyl PC PPAR.gamma. PPARgamma receptors thiazolidinediones binding sites atherosclerosis 2.884056827150
10007185 PCSK9 (human) Polyclonal Antibody - 2005-11-30 24.572722967640 pcsk9-human-polyclonal-antibody NARC-1; Proprotein Convertase Subtilisin Kexin 9 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases family lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols livers kidneys lungs spleens jejunums ileums colons muscles golgi tissues atherosclerosis immunoblotting 24.572722967640
10218 PCSK9 Monoclonal Antibody (Clone 15A6) - 2008-10-29 12.266548802946 pcsk9-monoclonal-antibody-clone-15a6 Proprotein Convertase Subtilisin Kexin 9; NARC-1 antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots 12.266548802946
10008811 PCSK9 (mouse) Polyclonal Antibody - 2007-01-22 10.554704856063 pcsk9-mouse-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 immunoblot neural apoptosis regulated convertase 1 atherosclerosis proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols atherosclerosis PCSK-9 immunoblotting 10.554704856063
10240 PCSK9 Polyclonal Antibody - 2009-07-21 4.278296500920 pcsk9-polyclonal-antibody NARC-1; Proprotein Convertase Subtilisin Kexin 9 PCSK-9 PCSK 9 western blots ICC WB immunocytochemistry protease LDLs lipoproteins low-density low density cholesterol immunoblotting blotting 4.278296500920
10009567 PCSK9 Western Ready Control - 2007-01-31 7.817861089187 pcsk9-western-ready-control Proprotein Convertase Subtilisin Kexin 9; NARC-1 PSEC0052 subtilisin serine proteases LDLs low density lipoproteins cholesterol receptors golgi atherosclerosis 7.817861089187
10010518 PD 146176 4079-26-9 ≥98% 2009-02-25 18.308729669749 pd-146176 NSC 168807 atherosclerosis 15-LOs 15-lipoxygenases oxidant injury injuries apoptosis amyloid β proteins inhibitors inhibits inhibitions Alzheimers disease oxidative stress pd146176 18.308729669749
101707 PGC-1 Polyclonal Antibody - 2005-10-12 27.193957810145 pgc-1-polyclonal-antibody PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting 27.193957810145
10044 PGPC 89947-79-5 >98% 2004-01-21 3.828968692449 pgpc PPAR.gamma. PPARgamma oxidized LDL lipds agonists atherosclerosis nuclear receptors thiazolidinediones sites peroxisome low-density lipoproteins e-selectin vcam1 vcam-1 binding 3.828968692449
10009926 Phosphatidylcholine Assay Kit - 2007-07-10 46.621197053406 phosphatidylcholine-assay-kit PC Assay Kit assays kits ceramides phospholipids atherosclerosis phosphorylcholines phosphocholines glycerol cells membranes fatty acids lipoproteins homeostasis sphingomyelin SM atherosclerosis atherosclerotic lesions serums plasmas quantifying quantification colorimetric PC PLD phospholipases 46.621197053406
19020 Pinane Thromboxane A2 71111-01-8 >98% 14.260674033149 pinane-thromboxane-a2 PTA2; Pinane TXA2 Thromboxanes analogs TXA2 antagonists TP receptors atherosclerosis 14.260674033149
10031 POV-PC 121324-31-0 >98% 13.112946593001 pov-pc 2-(5-oxovaleryl) Phosphatidylcholine oxidative injury lipids stress oxLDL oxidized low-density lipoproteins CD36 CD-36 PMNLs polymorphonuclear leukocytes atherosclerosis phosphatidylcholines scavengers receptors LPS-binding affinity potent structural determinant inhibits inhibition inhibitors lipopolysaccaride atherosclerosis 13.112946593001
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 56.225207182320 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 56.225207182320
101710 PPARα Polyclonal Antibody - 26.564855739717 ppar-polyclonal-antibody Peroxisome Proliferator-activated Receptor α peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a antibodies ligands ligand-activated activates activated lipids homeostasis fatty acids FAAH NSAIDs prostaglandins PGs luekotrienes LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic drugs transcriptionally regulates regulated regulation genes enzymes proteins metabolism oxidation acyl-CoA CoA oxidase enol-CoA hydratase chains dehydrogenase transports cytochrome P450 4A isoenzymes northern blots blotting immunoblotting liver skeletal muscle hearts kidney amino acids Atherosclerosis 26.564855739717
10006915 PPARα Transcription Factor Assay Kit - 2005-08-25 55.515160870978 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 55.515160870978
10008878 PPARα, δ, γ Complete Transcription Factor Assay Kit - 2006-08-22 38.534629044988 ppar-complete-transcription-factor-assay-kit PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric 38.534629044988
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 27.604745242480 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 27.604745242480
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 33.559779005524 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 33.559779005524
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 20.752995702885 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 20.752995702885
71000 PPARγ Ligand Pack - >98% 44.918631062001 ppar-ligand-pack Peroxisome Proliferator-activated Receptor γ Pack ligands ppar.gamma. ppargamma receptors antagonists antidiabetic diabetes peroxisome nuclear receptors proliferator-activated 15-deoxy-delta12,14-PGJ2 rosiglitazone ciglitazone troglitazone MCC-555 MCC555 thiazolidinediones TZD GW9662 GW-9662 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 nuclear receptors pioglitazone (potassium salt) 71740 18570 71742 70735 71745 10004272 GW 501516 GW501516 atherosclerosis packs 44.918631062001
10007685 PPARγ Ligand Screening Assay Kit - 2009-07-16 45.958161727774 ppar-ligand-screening-assay-kit Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green FP-based peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists 45.958161727774
101700 PPARγ Polyclonal Antibody - 18.013737174427 ppar-polyclonal-antibody Peroxisome Proliferator-activated Receptor γ peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g antibodies ligands ligand-activated activated activates activated transcription factors lipids homeostasis regulator regulates adipogenesis mRNA tissues large small intestines kidneys livers genes PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ1 PPAR-γ-1 PPAR-gamma1 PPAR-gamma-1 PPAR-.gamma.1 PPAR-.gamma.-1 PPAR-g-1 PPAR-g1 PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ2 PPAR-γ-2 PPAR-gamma2 PPAR-gamma-2 PPAR-.gamma.2 PPAR-.gamma.-2 PPAR-g-2 PPAR-g2 amino acids western blots immunoblotting blotting WB atherosclerosis endocrinology metabolism nuclear receptors 18.013737174427
10006855 PPARγ Transcription Factor Assay Kit - 2005-08-25 58.531583793738 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 58.531583793738
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 13.889472068754 ppar-human-recombinant NUC1; PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 13.889472068754
101720 PPARδ Polyclonal Antibody - 2004-11-05 14.570783525866 ppar-polyclonal-antibody Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies 14.570783525866
10006914 PPARδ Transcription Factor Assay Kit - 2005-08-23 30.800928867402 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 30.800928867402
10009568 PPARδ Western Ready Control - 2007-02-02 3.709790055248 ppar-western-ready-control Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1 peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity 3.709790055248
10010343 Pravastatin (sodium salt) 81131-70-6 ≥98% 2008-03-04 17.938365780935 pravastatin-sodium-salt atherosclerosis HMGCoA HMG-CoA reductase LDL-c HDL-c statins cholesterol heart diseases CVD pravachol lipostat inhibitors inhibits inhibitions cardiovascular 17.938365780935
10011724 Propenyl-L-NIO (hydrochloride) Exclusive - ≥90% ✓ 2008-08-19 8.798936464088 propenyl-l-nio-hydrochloride ENIPO nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition 8.798936464088
10008841 Propylpyrazole Triol 263717-53-9 ≥98% 2007-01-25 89.196277624309 propylpyrazole-triol PPT 17b-estrogen 17beta-estrogen 17.beta.-estrogen receptors ERalpha ER.alpha. ERbeta ER.beta. agonist ischemia DPN diarylpropinitrile in vivo infarct endocrinology 89.196277624309
13010 Prostaglandin E1 745-65-3 >98% 48.090448127685 prostaglandin-e1 Alprostadil; PGE1 PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1 48.090448127685
313010 Prostaglandin E1-d4 - ≥99% deuterated forms (d1-d4) 26.785285451197 prostaglandin-e1-d4 Alprostadil-d4; PGE1-d4 GC/MS deuterium isotopes PGE1-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry atherosclerosis 26.785285451197
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 26.335432780847 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 active PTGES 26.335432780847
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 10.028004143646 prostaglandin-e-synthase-1-microsomal-western-ready-control mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 PTGES 10.028004143646
17020 Prostaglandin H2 42935-17-1 >95% 162.105193370166 prostaglandin-h2 PGH2 PGH2 endoperoxides cyclooxygenase vasoconstrictors prostaglandins PGHS2 syntahses cox-2 cox2 PGHS-2 atherosclerosis 162.105193370166
18220 Prostaglandin I2 (sodium salt) 61849-14-7 ≥99% 83.555215469612 prostaglandin-i2-sodium-salt Prostacyclin; Epoprostenol; PGI2 PGI2 metabolites prostaglandins salts Na+ COX cyclooxygenases atherosclerosis 83.555215469612
18300 Prostaglandin I3 (sodium salt) Exclusive 68324-96-9 >99% ✓ 79.737679558011 prostaglandin-i3-sodium-salt PGI3 (Na salt) w-3 omega-3 PGI3 prostaglandins atherosclerosis .omega.-3 salts Na+ 79.737679558011
160630 Prostaglandin I Synthase Monoclonal Antibody (Clone isn-1) - Protein-A purified 4.454613259668 prostaglandin-i-synthase-monoclonal-antibody-clone-isn-1 Prostacyclin Synthase; PGIS; PGI Synthase synthases endothelium PGI2 prostaglandins antibodies antisera antiserum Bovine PGI synthase atherosclerosis neurochemistry IP immunoprecipitation IHC immunohistochemistry 4.454613259668
100023 Prostaglandin I Synthase (murine) Polyclonal Antibody - 2004-06-30 14.377154696132 prostaglandin-i-synthase-murine-polyclonal-antibody PGIS; Prostacyclin Synthase; PGI Synthase antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting 14.377154696132
160640 Prostaglandin I Synthase Polyclonal Antibody - 8.655893186003 prostaglandin-i-synthase-polyclonal-antibody Prostacyclin Synthase; PGIS; PGI Synthase PGIS prostacyclin synthases endothelium Western blots PGI2 prostaglandins blotting antisera antiserum immunoprecipitation IP antibodies atherosclerosis WB immunoblotting 8.655893186003
13294 Pyrrophenone 341973-06-6 ≥90% 2010-04-07 48.304680347276 pyrrophenone phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory Pyrrolidines 48.304680347276
10006217 Renin (human recombinant) - >99% by SDS-PAGE 2004-12-13 53.759364640884 renin-human-recombinant enzymes aspartyl proteases angiotensins II glycoproteins angiotensinogen salt balance hypertension angiotensinogens kidney renal preprorenin atherosclerosis endocrinology active 53.759364640884
10006270 Renin Inhibitor Screening Assay Kit - 2005-05-04 55.100208717004 renin-inhibitor-screening-assay-kit Protease measurement assays aspartyl renal juxtaglomerular cells sodium depletion blood volume pressure .beta.-adrenergic stimulation angiotensinogens angiotensins I II converting ACE monomeric zinc metalloenzymes vascular endothelium messengers RAS vasoconstrictor peripheral hypertension receptors blockers fluorescence fluorescent fluorometric atherosclerosis endocrinology 55.100208717004
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 256.332392917195 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 256.332392917195
13900 Resveratrol-3-O-Sulfate 553662-69-4 ≥98% 2011-06-01 14.665722178374 resveratrol-3-o-sulfate polyphenol phytoalexin biochemicals physiological actions estrogenic antiplatelet anti-inflammatory piceid polydatin grape juices glucuronidated metabolites humans 14.665722178374
579070 Retinol Binding Protein 4 (human) Competitive EIA Kit - 2011-08-01 7.725669358266 retinol-binding-protein-4-human-competitive-eia-kit RBP4 binding proteins EIAs ELISAs enzymes immunoassays kits measures measurement insulin glucose homeostasis uptake skeletal muscles adipose tissues transporter 4 GLUT4 resistance vitamins A adipokines metabolic obesity syndromes cardiovascular diseases expression pro-inflammatory cytokines LDLs low-density lipoproteins cholesterols diet-induced obese hyperlipidemic hyperlipidemia dyslipidemia lipids metabolisms serums plasmas disorders 7.725669358266
10006415 Ro 48-8071 161582-11-2 ≥98% 2005-06-01 8.098516179952 ro-48-8071 monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis 8.098516179952
71740 Rosiglitazone 122320-73-4 ≥98% 156.772103540003 rosiglitazone BRL 49653 BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome atherosclerosis endocrinology 156.772103540003
10011343 Rosiglitazone-d5 Maleate - >99% deuterated product 2009-04-04 37.339193370166 rosiglitazone-d5-maleate SPI TZDs thiazolinedions PPARg PPAR.gamma. PPARgamma selective ligand insulin resistance anti-inflammatory 37.339193370166
71742 Rosiglitazone (potassium salt) 316371-84-3 >98% 62.633134103465 rosiglitazone-potassium-salt BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome salts thiazolidinediones atherosclerosis endocrinology 62.633134103465
10005260 Serine Palmitoyltransferase Polyclonal Antibody - 2004-12-02 27.109856353591 serine-palmitoyltransferase-polyclonal-antibody Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting 27.109856353591
10007681 Serum Retinol Binding Protein 4 Polyclonal Antibody Exclusive - ✓ 2007-08-03 4.724127071822 serum-retinol-binding-protein-4-polyclonal-antibody Plasma Retinol Binding Protein 4; pRBP; sRBP4 vitamin A wb western blotting type 2 diabetes lipocalin TTR transthyretin sRBP4 sRBP-4 proteins adipocytes signals signalling signaling insulin blots retinols serums RBP atherosclerosis endocrinology immunoblotting 4.724127071822
10010344 Simvastatin 79902-63-9 ≥98% 2008-02-27 23.698791984565 simvastatin MK 733 HMG-CoA reductase HMGCoA inhibits inhibitors inhibition LDL-c HDL-c statins cholesterol heart diseases CVD atherosclerosis zocor zetia exetimibe vytorin inegy TNF-.alpha. NF-.kappa.B apoptosis cancers cardiovascular NFkB atherosclerosis 23.698791984565
10010345 Simvastatin (sodium salt) New 101314-97-0 ≥98% 2012-03-06 21.730877839165 simvastatin-sodium-salt Zocor™ 79002-63-9 12009-77-6 121009-77-6 343252-47-1 atherosclerosis HMG-CoA reductase LDL LDL-c HDL HDL-c statins cholesterol hearts diseases CVD zetia ezetimibe vytorin inegy TNF-α TNFα NF-κB NFκB apoptosis cancers inhibitors inhibits inhibition enzymes dogs humans leukemia cells 21.730877839165
10010146 Soluble Epoxide Hydrolase Polyclonal Antibody - 2008-03-03 6.894585635359 soluble-epoxide-hydrolase-polyclonal-antibody Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH) metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting 6.894585635359
10006964 Sphingomyelinase Assay Kit - 2009-11-25 79.522564712502 sphingomyelinase-assay-kit SMase Assay Kit sphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNases I superfamily sphingomyelins phosphorylcholines ceramides cells cellular stress cations lysosomal acids secreted zinc-dependent membrane-bound magnesium-dependent neutral cytosolic magnesium-independent neutral alkalines mutations ASM genes Type A B Niemann-Pick diseases physiological pathophysiological lysosomal digestion neuronal vascular ceramide-mediated signal transduction cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessel walls atherogenesis intracellular trafficking metabolism assays kits measures measuring measurements acidic activity tissues homogenates lysates serum blood saliva urine coupled enzymatic reactions oxidases betaine h2o2 hydrogen peroxides horseradish peroxidases HRPs 10-acetyl-3,7-dihydroxyphenozazine ADHP fluorescent fluorescence 79.522564712502
700330 Sphingomyelinase Inhibitor Screening Assay Kit - 2010-02-09 42.857868184608 sphingomyelinase-inhibitor-screening-assay-kit SMase assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols 42.857868184608
19025 SQ 29,548 98672-91-4 ≥98% 95.835127071823 sq-29-548 thromboxanes TXA2 SQ-29548 SQ29548 analogs TP antagonists receptors atherosclerosis 95.835127071823
10010854 SREBP-1 Transcription Factor Assay Kit - 2008-06-24 30.849917127071 srebp-1-transcription-factor-assay-kit Sterol Regulatory Element-Binding Protein-1 Assay Kit tf atherosclerosis SREBPs sterols regulatory element binding proteins factors basic helix-loop-helix-leucine zipper family expression regulate synthesis regulation uptake cholesterol fatty acids triglycerides phospholipids adipocyte differentiation insulin-dependent genes SREBP-1a membrane-bound rough ER endoplasmic reticulum cleavage activating SREBP-Scap Golgi proteolytic two-step cleavage S1P S2P NH2 -terminal active domain nuclear localization signal importin nucleus upregulating genes fatty acids lipogenic enzymes acetyl CoA coenzymes A carboxylases synthases long chain elongases glucose glucokinases glycolysis diseases obesity diabetes mellitus insulin resistance non-alcoholic liver non-radioactive sensitve sensitivity detects detecting double stranded dsDNA extracts ELISA EMSA humans rats mouse mice murine SREBP1C SREBP 1c assays 30.849917127071
10009266 SREBP-2 Blocking Peptide - 2006-10-18 46.587486187845 srebp-2-blocking-peptide SREBF2; Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein-2 signaling signalling controls peptides proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry atherosclerosis 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds nucleus cells livers brown fats testis HepG2 human fibroblasts 46.587486187845
10009239 SREBP-2 Cell-Based Translocation Assay Kit - 2007-04-17 38.243011505570 srebp-2-cell-based-translocation-assay-kit Sterol Regulatory Element-Binding Protein-2 Cell-Based Translocation Assay Kit sterol regulatory element binding proteins athersclerosis cholesterols fatty acids triglycerides phospholipids helix-loop-helix HLH transcription factors DyLight Pierce Biotechnology assays fluorescence fluorescent fluorometric cell-based assays cell based assay cba U18666A U 18666A U-18666A 38.243011505570
10007663 SREBP-2 Polyclonal Antibody - 2006-02-22 74.763551696922 srebp-2-polyclonal-antibody Sterol Regulatory Element-binding Transcription Factor 2; SREBF2; Sterol Regulatory Element-binding Protein-2 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds proteins nucleus cells livers brown fats testis HepG2 human fibroblasts endocrinology immunoblotting 74.763551696922
10007819 SREBP-2 Transcription Factor Assay Kit - 2006-09-20 33.954438881215 srebp-2-transcription-factor-assay-kit Sterol Regulatory Element-binding Protein-2 Assay Kit tf sterol regulatory element binding proteins cholesterol fatty acids triglycerides phospholipids atherosclerosis assays 33.954438881215
10009749 SREBP-2 Western Ready Control - 94 kDa (GST-tagged); 68 kDa (native) 2007-07-30 14.372972375690 srebp-2-western-ready-control Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2 WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis 14.372972375690
10011298 Stearic Acid 57-11-4 ≥98% 2008-10-10 4.128574676579 stearic-acid saturated fatty acids trans LDLs HDLs liporotein cholesterols dietary fats atherosclerosis 4.128574676579
10026 T0070907 313516-66-4 ≥98% 44.348055248618 t0070907 T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology 44.348055248618
71810 T0901317 293754-55-9 ≥98% 179.821464088397 t0901317 agonists to901317 TO-901317 T-0901317 t0-901317 receptors lipid nuclear hormone LXR.alpha.nuclear receptors LXR.beta. LXRalpha LXRbeta atherosclerosis 179.821464088397
10009911 Tangeritin 481-53-8 ≥98% 2008-12-16 11.780883977900 tangeritin Ponkanetin; NSC 618905; NSC 53909 flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma 11.780883977900
10007349 TGX-221 663619-89-4 >98% 2006-02-21 19.982782800379 tgx-221 phosphatidylinositol-3-kinases PI3K catalyzes phosphorylation produces second messengers (3,4)-biphosphates -P2 (3,4,5)-P3 Class 1 p110.alpha. .beta. .delta. .gamma. p85 regulatory subunits cells permeable inhibitors inhibition inhibits ATP binding sites platelets defective thrombus formation antithrombotic therapy atherosclerosis 19.982782800379
19030 Thromboxane B2 54397-85-2 ≥99% 103.580638428483 thromboxane-b2 TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis 103.580638428483
160720 Thromboxane B2 11-dehydrogenase Polyclonal Antiserum - 15.848353591160 thromboxane-b2-11-dehydrogenase-polyclonal-antiserum TXB2 11-dehydrogenase; Aldehyde Dehydrogenase; ALDH1; Retinal Aldehyde Dehydrogenase Western blots blotting erythrocyte thromboxanes TXB2 antisera antibodies antiserum WB atherosclerosis immunoblotting 15.848353591160
319030 Thromboxane B2-d4 - ≥99% deuterated product 44.321860036832 thromboxane-b2-d4 TXB2-d4 GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry atherosclerosis prostaglandins TXB2-d4 thromboxanes deuterated 44.321860036832
519031 Thromboxane B2 EIA Kit - 455.493950327399 thromboxane-b2-eia-kit solid plates TXB2 thromboxanes measures kits eias enzyme atherosclerosis immunoassays ELISAs assays 455.493950327399
10004023 Thromboxane B2 Express EIA Kit - Monoclonal - 2004-07-02 117.551852993026 thromboxane-b2-express-eia-kit-monoclonal TXB2 Express ELISA Kit - Monoclonal; TXB2 Express EIA Kit (Monoclonal) solid plates atherosclerosis thromboxanes measures kits eias enzyme immunoassays ELISAs intrarenal TXA2 synthesis fast same-day assays 117.551852993026
10007237 Thromboxane B2 Lipid Maps MS Standard 54397-85-2 ≥99% 2009-01-16 22.881335174954 thromboxane-b2-lipid-maps-ms-standard TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis MS mass spectrometry standards 22.881335174954
19990 Thromboxane B3 71953-80-5 >98% 5.702817679558 thromboxane-b3 TXB3; Δ17-TXB2 .DELTA.17-TXB2 Thromboxanes TXB3 TXA3 omega-3 .omega.-3 w-3 d17-TXB2 DELTA17-TXB2 atherosclerosis 5.702817679558
160715 Thromboxane Synthase Polyclonal Antibody - 10.431889502762 thromboxane-synthase-polyclonal-antibody TX Synthase prostaglandins PGH2 platelet aggregation thromboxanes TXS Synthases western blots blotting WB antibodies antisera antiserum IHC immunohistochemistry atherosclerosis immunoblotting 10.431889502762
10010516 TMP-153 New 128831-46-9 ≥95% 2012-05-08 82.914836446549 tmp-153 Acyl-CoA:cholesterol acyltransferases ACAT cholesterol esterification atherosclerosis inhibitors inhibits inhibition LDL TMP153 TMP-153 cells fatty acids intestinal absorption vascular tissues plasma lipids proteinuria low density lipoprotein high HDL HepG2 L-S180 LS180 L S180 82.914836446549
10005263 TOFA 54857-86-2 ≥98% 2004-07-28 23.026243093922 tofa RMI 14514; 5-(Tetradecyloxy)-2-furoic Acid inhibits inhibitors inhibition ACC acetyl-CoA carboxylases fatty acid synthases synthesis FAS cerulenin apoptosis cancer C75 malonyl-CoA atherosclerosis endocrinology 23.026243093922
10004452 TP Receptor (human) Polyclonal Antibody - 2004-04-01 107.429983425413 tp-receptor-human-polyclonal-antibody TXA2 Receptor; Thromboxane A2 Receptor thromboxanes platelets metabolites TXA2 IHC immunohistochemistry antibodies antisera antiserum western blot blotting WB atherosclerosis immunoblotting ICC immunocytochemistry 107.429983425413
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 56.391240024554 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting 56.391240024554
13044 Tranilast 53902-12-8 ≥98% 2008-08-29 71.116731123388 tranilast SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF 71.116731123388
70675 trans-Resveratrol 501-36-0 >98% 90.910582583043 trans-resveratrol (E)-Resveratrol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes AHR antagonists aryl hydrocarbon receptors 90.910582583043
13130 trans-Resveratrol-d4 - ≥99% deuterated product 2009-01-14 20.881717311234 trans-resveratrol-d4 (E)-Resveratrol-d4 selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors 20.881717311234
10162 Treprostinil 81846-19-7 >98% 2005-08-30 75.237668508287 treprostinil Remodulin® primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® 75.237668508287
71750 Troglitazone 97322-87-7 >98% 69.170685082872 troglitazone ResulinTM antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology 69.170685082872
10009085 U-18666A 3039-71-2 >95% 2007-01-19 28.064353591161 u-18666a Niemann-Pick type C NPC apoptosis neuronal death Alzheimers AD neurodegeneratives diseases trafficking unesterified ER cells membranes cateracts epilepsy Free cholesterol loading NSC 70801 Endoplasmic reticulum atherosclerosis inhibits inhibitors inhibition endosomes lysomes oxidosqualene cyclases atherosclerosis 28.064353591161
16440 U-44069 56985-32-1 >98% 235.746519337017 u-44069 9,11-dideoxy-9α,11α-epoxymethano Prostaglandin F2α; 9,11-dideoxy-9α,11α-epoxymethano PGF2α; 9,11-epoxymethano Prostaglandin H2 endoperoxides methanoepoxy PGH2 thromboxanes analogs prostaglandins U44069 TP receptors agonists atherosclerosis 235.746519337017
16450 U-46619 56985-40-1 >98% 225.073822199899 u-46619 9,11-dideoxy-9α,11α-methanoepoxy Prostaglandin F2α; 9,11-dideoxy-9α,11α-methanoepoxy PGF2α endoperoxides PGH2 thromboxanes vasoconstriction analogs TP receptors agonists U46619 atherosclerosis 225.073822199899
16465 U-51605 64192-56-9 >98% 48.083149171271 u-51605 diazo endoperoxides inhibitors U51605 analogs PGH2 PGIs synthase prostaglandins inhibits thromboxanes atherosclerosis 48.083149171271
10003 Vasoactive Eicosanoid HPLC Mixture - >98% for each compound 22.617585635359 vasoactive-eicosanoid-hplc-mixture 11-dehydro-TXB2 2,3-dinor-6-keto-PGF1.alpha. 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-TXB2 12-HHTs 12(S)-HHTrEs 12-HHTrEs 12(S)HHTrEs thromboxanes prostaglandins eicosanoids mixtures 2,3-dinor-PGF1.alpha. 2,3-dinor-PGF1alpha chromatography atherosclerosis 22.617585635359
70730 Wy 14643 50892-23-4 ≥98% 55.026270718232 wy-14643 Pirinixic Acid activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 55.026270718232
18113 YM-53601 Exclusive 182959-33-7 ≥98% ✓ 2009-08-11 8.449790055248 ym-53601 squalene synthases inhibitors cholesterol triglycerides HMG-CoA reductase fibrates hyperlipidemia hypercholesterolemia lipid-lowering activities inhibitor inhibited 8.449790055248
71800 (Z)-Guggulsterone 39025-23-5 ≥98% 2009-12-01 1.169042357274 -z-guggulsterone anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt 1.169042357274
90210 α-Linolenic Acid 463-40-1 >98% 13.907580110497 -linolenic-acid ALA fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 essential leafy green vegetables alpha-linolenic .alpha.-linolenic 13.907580110497
9000433 α-Linolenic Acid-d14 - ≥99% deuterated forms (d1-d14) 2010-09-13 8.445831798649 -linolenic-acid-d14 ALA-d14 fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic 8.445831798649
16460 Δ17-U-46619 - >98% 80.950207182320 -17-u-46619 d17-u-46619 delta17-u-46619 .delta.17-u-46619 thromboxanes TXA3 analogs agonists d17-u46619 delta17-u46619 .delta.17-u46619 atherosclerosis 80.950207182320
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?